secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001567264-25-000042
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics receives Nasdaq non-compliance notice for stockholders' equity
--------------------------------------------------------------------------------

- Nasdaq notified company on May 19, 2025 of failure to meet minimum $2.5M stockholders' equity requirement.
- Company has until July 3, 2025 to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant up to 180-day extension from notice date.
- Failure could lead to delisting of common stock (INTS); no immediate effect on listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000042/0001567264-25-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000042/intensity-20250519.htm
  HTML page:      https://secwatch.observer/filing/0001567264-25-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer